Alex Zhavoronkov, founder & CEO of Insilico Medicine, stated that he “firmly believes that the repurposing of FDA-approved drugs with demonstrated anti-ageing potential represents a highly ...

and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, is the study director of an international clinical trial that finds an anti-amyloid drug can delay the onset of cognitive ...

This trial, which focused on anti-amyloid drugs, was set up in 2012 when the participants had either no symptoms or just mild cognitive symptoms. At this stage, they were within 15 years before to ...